Back to INBX
HighTower Advisors, LLC → INBX
HighTower Advisors, LLC INBX Position History
Inhibrx Biosciences, Inc. • Healthcare
Quarters held
5
Latest value
$88.5M
Q3 2026
Peak value
$88.5M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $29.4M |
| Q4 2025 | $68.8M |
| Q1 2026 | $58.5M |
| Q2 2026 | $82.5M |
| Q3 2026 | $88.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $88.5M | 884.4K | — | — |
| Q2 2026 | $82.5M | 870.6K | — | — |
| Q1 2026 | $58.5M | 870.2K | — | — |
| Q4 2025 | $68.8M | 870.5K | — | — |
| Q3 2025 | $29.4M | 871.8K | — | — |
Other funds holding INBX
$271.7M
$172.4M
$131.2M
$129.3M
$126.4M
$125.3M